ARTICLE | Distillery Therapeutics
Cancer
January 9, 2018 10:05 PM UTC
Mouse studies suggest inhibiting PTPN22 on CD8+ T cells could help treat TGFβ-RII-expressing thymoma. In a mouse model of TGFβ-RII-expressing thymoma, CD8+ T cell-specific knockout of PTPN22 decreased...
BCIQ Company Profiles